lenvatinib,nivolumab
eisai pharmaceutical,bms
['immunib', 'nivo', 'nivolumab', 'hcc']
first analysis of our immunib trail in hcc nivolumab and lenvatinib as 1st line therapy in advanced hcc. very interesting orr and os data, albeit still early.
#livercancer #hcc 
Physician-scientist, focussed on translational research in hepatobiliary cancer and precision medicine